Search Results - Lisa H Butterfield
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al by Lisa H Butterfield, Hideho Okada, Sabine Mueller, Zinal S Chheda, Bindu Hegde, Akane Yamamichi
Published in Journal for ImmunoTherapy of Cancer (2023-03-01)Get full text
Article -
4
-
5
Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab by Yan Lin, Lisa H. Butterfield, Ahmad A. Tarhini, Janet Retseck, Robert VanderWeele, Hui-Min Lin
Published in Journal for ImmunoTherapy of Cancer (2016-06-01)Get full text
Article -
6
-
7
Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients by Juraj Adamik, Paul V. Munson, Deena M. Maurer, Felix J. Hartmann, Sean C. Bendall, Rafael J. Argüello, Lisa H. Butterfield
Published in Nature Communications (2023-11-01)Get full text
Article -
8
The future of cancer immunotherapy for brain tumors: a collaborative workshop by Christine E. Brown, Samantha Bucktrout, Lisa H. Butterfield, Olga Futer, Evanthia Galanis, Adilia Hormigo, Michael Lim, Hideho Okada, Robert Prins, Sara Siebel Marr, Kirk Tanner
Published in Journal of Translational Medicine (2022-05-01)Get full text
Article -
9
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art by Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, David R. Kaufman, Samir N. Khleif, Ena Wang, on behalf of the Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers
Published in Journal for ImmunoTherapy of Cancer (2018-12-01)Get full text
Article -
10
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021 by Paolo A. Ascierto, Lisa H. Butterfield, Olivera J. Finn, Andrew Futreal, Omid Hamid, Theresa LaVallee, Michael A. Postow, Igor Puzanov, Jeffrey Sosman, Bernard A. Fox, Patrick Hwu
Published in Journal of Translational Medicine (2022-04-01)Get full text
Article -
11
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule by Jerome Galon, Sandra Demaria, Lisa H. Butterfield, Robert L. Ferris, Howard L. Kaufman, Willem W. Overwijk, Francesco M. Marincola, Pamela S. Ohashi, Ira Mellman, Pierre G. Coulie, Samir N. Khleif, Suzanne L. Topalian
Published in Journal for ImmunoTherapy of Cancer (2016-11-01)Get full text
Article -
12
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation by Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Published in Journal for ImmunoTherapy of Cancer (2016-12-01)Get full text
Article -
13
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations by Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Published in Journal for ImmunoTherapy of Cancer (2016-12-01)Get full text
Article -
14
Immune oncology, immune responsiveness and the theory of everything by Tolga Turan, Deepti Kannan, Maulik Patel, J. Matthew Barnes, Sonia G. Tanlimco, Rongze Lu, Kyle Halliwill, Sarah Kongpachith, Douglas E. Kline, Wouter Hendrickx, Alessandra Cesano, Lisa H. Butterfield, Howard L. Kaufman, Thomas J. Hudson, Davide Bedognetti, Francesco Marincola, Josue Samayoa
Published in Journal for ImmunoTherapy of Cancer (2018-06-01)Get full text
Article -
15
45 An integrative immune signature of complementary circulating and tumoral biomarkers maximizes the predictive power of adjuvant immunotherapeutic benefits for high-risk melanoma... by Lisa H Butterfield, Howard Streicher, Patrick Hwu, Walter J Storkus, Ahmad A Tarhini, John M Kirkwood, F Stephen Hodi, Dung-Tsa Chen, Sandra J Lee, Issam El Naqa, William A LaFramboise, Arivarasan D Karunamurthy, Timothy I Shaw, Alyssa Obermayer
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
16
Systematic evaluation of immune regulation and modulation by Francesco Marincola, David F Stroncek, Barbara Seliger, Lisa H. Butterfield, David R. Kaufman, Firouzeh Korangy, Sergio Rutella, Peter P. Lee, Madhav V. Dhodapkar, Michael A. Cannarile, Tim F. Greten, Jean Charles Grivel, Heidi H. Kong, Janet C. Siebert, Giorgio Trinchieri
Published in Journal for ImmunoTherapy of Cancer (2017-08-01)Get full text
Article -
17
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy) by Paolo A. Ascierto, James Brugarolas, Luigi Buonaguro, Lisa H. Butterfield, David Carbone, Bruno Daniele, Robert Ferris, Bernard A. Fox, Jérôme Galon, Cesare Gridelli, Howard L. Kaufman, Christopher A. Klebanoff, Ignacio Melero, Paul Nathan, Chrystal M. Paulos, Marco Ruella, Ryan Sullivan, Hassane Zarour, Igor Puzanov
Published in Journal for ImmunoTherapy of Cancer (2018-07-01)Get full text
Article -
18
Immunotherapy biomarkers 2016: overcoming the barriers by Jeffrey Schlom, Lisa H Butterfield, Jianda Yuan, Alessandra Cesano, Janet Siebert, Barbara Seliger, Jay A. Berzofsky, James L. Gulley, Holden Maecker, Bernard A. Fox, Marcus O. Butler, Cristina Maccalli, Sacha Gnjatic, Vaios Karanikas, Ilan Kirsch, Sylvia Janetzki, Samir N. Khleif, Magdalena Thurin, Peter P. Lee, Shyam Kalavar, David F. Stroncek
Published in Journal for ImmunoTherapy of Cancer (2017-08-01)Get full text
Article -
19
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study by Lisa H Butterfield, John E Connolly, Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, Aik Choon Tan, Kevan C Herold, Zoe Quandt, Anastasia Lucas, Arabella Young, Christine N Spencer, Lacey J Padron, Samantha I Liang, EnJun Yang, Samantha Stone, Muhammad Zaki Hidayatullah Fadlullah, Sara Siebel Marr, Marshall A Thompson, Mark S Anderson
Published in Journal for ImmunoTherapy of Cancer (2025-05-01)Get full text
Article -
20
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee by Lisa H Butterfield, Howard L Kaufman, Steven A Rosenberg, Simon Turcotte, Robert L Ferris, Craig L Slingluff, David Byrd, Jyothi Sethuraman, Brian Gastman, Michael Lim, Michael T Lotze, Mokenge Malafa, Adekunle Odunsi, Fumito Ito, Genevieve Boland, Pranav Murthy, Adam Berger, Haider Mahdi, Piyush K Agarwal, Stephen Broderick, Peter E Fecci, Yuman Fong, Stephanie L Goff, Matthew M Grabowski, Carol D Morris, Rogerio I Neves, Sara I Pai, Sangeetha Prabhakaran, Ragheed Saoud, Joseph Skitzki, Vernon K Sondak, John B Sunwoo, Cecilia CS Yeung
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article
